Chemiesynth (Vapi)

₹34.1 0 | 0%

WEBSITE BSE:539230 NSE : CHEMIESYNT 13 May, 00:00

Market Cap ₹10 Cr.

Stock P/E -26.9

P/B 0.9

Current Price ₹34.1

Book Value ₹ 36.9

Face Value 10

52W High ₹34.1

Dividend Yield 0%

52W Low ₹ 21

Edit Ratio

Chemiesynth (Vapi) Research see more...

Overview Inc. Year: 1986Industry: Chemicals

Chemiesynth (Vapi) Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Chemiesynth (Vapi) Quarterly Results

#(Fig in Cr.)	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Net Sales	10	7	5	4	7	5	4	4	3	4
Other Income	0	0	0	0	0	0	0	0	0	0
Total Income	10	7	5	4	7	5	4	4	3	4
Total Expenditure	8	7	5	4	6	4	4	3	3	4
Operating Profit	2	0	-0	0	1	1	-0	1	-0	0
Interest	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Exceptional Income / Expenses	0	1	0	0	0	0	0	0	0	0
Profit Before Tax	1	1	-1	0	1	0	-1	1	-1	-0
Provision for Tax	0	1	0	0	0	0	0	0	0	-0
Profit After Tax	1	0	-1	0	1	0	-1	1	-1	-0
Adjustments	0	0	0	0	0	0	-0	0	0	0
Profit After Adjustments	1	0	-1	0	1	0	-1	1	-1	-0
Adjusted Earnings Per Share	3.4	0.7	-2	0.2	2.7	0.9	-1.7	2.8	-1.7	-0.7

Chemiesynth (Vapi) Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	5	10	11	5	3	13	11	15	20	30	21	15
Other Income	0	0	0	0	0	0	0	0	0	0	0	0
Total Income	5	10	11	5	3	14	11	15	20	30	21	15
Total Expenditure	6	9	12	5	3	13	9	12	14	26	18	14
Operating Profit	-1	1	-0	-0	0	1	2	2	6	4	3	1
Interest	0	0	0	0	0	0	0	0	0	0	1	0
Depreciation	1	0	0	0	0	1	0	1	1	1	1	0
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	1	0	0
Profit Before Tax	-2	0	-1	-1	-0	0	1	2	4	4	1	-1
Provision for Tax	-0	0	0	0	0	0	0	0	1	1	0	0
Profit After Tax	-2	0	-1	-1	-0	0	1	1	4	3	1	-1
Adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	-2	0	-1	-1	-0	0	1	1	4	3	1	-1
Adjusted Earnings Per Share	-5.2	0.4	-3.2	-1.8	-0.6	1.3	3.8	4.3	11.6	8.8	1.8	-1.3

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	-30%	12%	10%	15%
Operating Profit CAGR	-25%	14%	25%	0%
PAT CAGR	-67%	0%	0%	0%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	88%	NA%	NA%	NA%
ROE Average	5%	29%	31%	7%
ROCE Average	6%	18%	17%	6%

Chemiesynth (Vapi) Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	4	4	3	2	2	2	4	5	8	11	12
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	5	5	6	7	7	7	7	7	9	8	8
Other Non-Current Liabilities	2	1	1	1	0	0	0	0	0	1	1
Total Current Liabilities	2	4	3	2	2	2	4	6	9	10	10
Total Liabilities	12	13	12	12	12	12	15	18	27	30	31
Fixed Assets	11	10	10	10	10	10	11	12	20	22	25
Other Non-Current Assets	0	0	0	0	0	0	1	2	0	1	1
Total Current Assets	1	3	2	1	2	2	4	4	6	7	6
Total Assets	12	13	12	12	12	12	15	18	27	30	31

Chemiesynth (Vapi) Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	0	0	0	0	0	0	0	1	0	0	1
Cash Flow from Operating Activities	-1	-0	-0	-2	-0	1	3	1	6	3	0
Cash Flow from Investing Activities	-0	0	0	-0	0	-0	-2	-3	-8	-3	-3
Cash Flow from Financing Activities	1	-0	-0	2	-0	-0	-0	2	1	1	2
Net Cash Inflow / Outflow	0	0	-0	-0	0	0	0	-0	0	1	-1
Closing Cash & Cash Equivalent	0	0	0	0	0	0	1	0	0	1	0

Chemiesynth (Vapi) Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	0	0	0	0	0	0	0	0	11.6	8.85	1.81
CEPS(Rs)	-3.14	1.18	-2.25	-1.11	-0	2.98	5.31	6.05	14.14	12.28	5.61
DPS(Rs)	0	0	0	0	0	0	0	0	0	0	0
Book NAV/Share(Rs)	0	0	0	0	0	0	0	0	27.55	36.39	38.2
Core EBITDA Margin(%)	-20.32	5.52	-3.8	-2.71	-2.55	4.85	17.33	15.71	28.03	14.82	12.27
EBIT Margin(%)	-30.59	4.34	-6.14	-6.16	0.35	4.35	13.76	12.73	24.2	14.43	6.72
Pre Tax Margin(%)	-37.87	1.19	-8.72	-10.62	-5.86	2.96	13	10.84	21.79	12.79	3.89
PAT Margin (%)	-30.37	1.19	-8.72	-10.62	-5.86	2.96	10.48	8.97	17.9	9	2.65
Cash Profit Margin (%)	-18.37	3.75	-6.19	-6.68	-0	6.88	14.56	12.74	21.82	12.49	8.22
ROA(%)	-12.27	0.89	-7.63	-4.55	-1.55	3.35	8.68	7.94	15.94	9.62	1.83
ROE(%)	-37.15	3.22	-31.04	-22.95	-8.8	17.79	39.1	30.81	53.35	27.67	4.85
ROCE(%)	-17.18	4.37	-7.04	-3.22	0.11	5.67	14.21	14.32	28.37	20.7	5.85
Receivable days	30.86	11.36	18.83	44.88	38.35	16.43	43.75	41.08	48.47	43.18	53.61
Inventory Days	62.27	47.19	40.01	50.24	95.72	18.3	25.6	37.58	29.55	21.77	44.16
Payable days	168.83	131.32	124.37	305.85	595.16	49.61	394.56	375.49	523.77	192.13	248.41
PER(x)	0	0	0	0	0	0	0	0	0	2.05	11.05
Price/Book(x)	0	0	0	0	0	0	0	0	0	0.5	0.52
Dividend Yield(%)	0	0	0	0	0	0	0	0	0	0	0
EV/Net Sales(x)	1.61	0.96	0.87	2.18	3.55	0.82	0.91	0.86	0.68	0.54	0.94
EV/Core EBITDA(x)	-8.64	13.85	-24.08	-98.13	57.14	9.95	5.12	5.2	2.42	3.6	7.68
Net Sales Growth(%)	-43.9	83.37	15.58	-54.01	-39.59	330.49	-15.88	30.03	36.62	51.69	-30.62
EBIT Growth(%)	-372.83	126.01	-263.51	53.8	103.42	5275.76	165.96	20.29	159.65	-9.56	-67.69
PAT Growth(%)	-6311	107.18	-947.66	43.98	66.67	317.7	197.48	11.35	172.54	-23.74	-79.55
EPS Growth(%)	0	0	0	0	0	0	0	0	172.53	-23.74	-79.55
Debt/Equity(x)	1.58	1.79	2.54	3.89	3.97	3.32	2.14	1.99	1.28	1.04	1.16
Current Ratio(x)	0.56	0.73	0.54	0.7	0.67	0.9	0.91	0.64	0.65	0.68	0.61
Quick Ratio(x)	0.23	0.25	0.31	0.38	0.26	0.73	0.63	0.34	0.5	0.46	0.3
Interest Cover(x)	-4.2	1.38	-2.38	-1.38	0.06	3.13	18	6.71	10.02	8.79	2.37
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0	0	2.08	2.22

Chemiesynth (Vapi) Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	62.35	62.35	62.35	62.35	62.35	62.35	62.35	62.35	62.35	62.35
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	37.65	37.65	37.65	37.65	37.65	37.65	37.65	37.65	37.65	37.65
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0.19	0.19	0.19	0.19	0.19	0.19	0.19	0.19	0.19	0.19
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12	0.12
Others	0	0	0	0	0	0	0	0	0	0
Total	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.31	0.31

Pros

Stock is trading at 0.9 times its book value
Company has a good return on equity (ROE) track record: 3 Years ROE 29%

Cons

Debtor days have increased from 192.13 to 248.41days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.